| Literature DB >> 30451049 |
Jaap J Tolk1, Rob P A Janssen1, C Sanna A C Prinsen2, M Marieke C van der Steen3, Sita M A Bierma Zeinstra4,5, Max Reijman1,5.
Abstract
Background and purpose - Improvement of physical function is one of the main treatment goals in severe hip osteoarthritis (OA) patients. The Osteoarthritis Research Society International (OARSI) has identified a core set of performance-based tests to assess the construct physical function: 30-s chair stand test (30-s CST), 4x10-meter fast-paced walk test (40 m FPWT), and a stair-climb test. Despite this recommendation, available evidence on the measurement properties is limited. We evaluated the reliability, validity, and responsiveness of these performance-based measures in patients with hip OA scheduled for total hip arthroplasty (THA). Patients and methods - Baseline and 12-month follow-up measurements were prospectively obtained in 90 end-stage hip OA patients who underwent THA. As there is no gold standard for comparison, the hypothesis testing method was used for construct validity and responsiveness analysis. A test can be assumed valid if ≥75% of predefined hypotheses are confirmed. A subgroup (n = 30) underwent test-retest measurements for reliability analysis. The Oxford Hip Score, Hip injury and Osteoarthritis Outcome Score-Physical Function Short Form, pain during activity score, and muscle strength were used as comparator instruments. Results - Test-retest reliability was appropriate; intraclass correlation coefficient values exceeded 0.70 for all 3 tests. None of the performance-based measures reached 75% hypothesis confirmation for the construct validity or responsiveness analysis. Interpretation - The performance-based tests have good reliability in the assessment of physical function. Construct validity and responsiveness, using patient-reported measures and muscle strength as comparator instruments, could not be confirmed. Therefore, our findings do not justify their use for clinical practice.Entities:
Mesh:
Year: 2018 PMID: 30451049 PMCID: PMC6366472 DOI: 10.1080/17453674.2018.1539567
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Responsiveness
| Predefined hypotheses | 3a0-s chair stand test (change score) | 40 m fast-paced walk test (change score) | 10-step stair climb test | |||
|---|---|---|---|---|---|---|
| Spearman correlation coefficient | Hypothesis confirmed | (change score) | Spearman correlation coefficient | Hypothesis confirmed | Spearman correlation coefficient | Hypothesis confirmed |
| 1. Moderate correlation with anchor question (≥ 0.4) | 0.37 | No | 0.28 | No | –0.18 | No |
| 2. Moderate correlation with change score NRS pain during activity (≤ –0.4) | –0.04 | No | –0.13 | No | 0.14 | No |
| 3. Moderate correlation with change score HOOS-PS (≤ –0.4) | 0.30 | No | 0.21 | No | –0.35 | No |
| 4. Moderate correlation with change OHS (≥ 0.4) | 0.23 | No | 0.27 | No | –0.26 | No |
| 5. Correlation between change scores NRS pain and HOOS-PS is minimal 0.1 stronger than between NRS pain and performance-based test | –0.45/–0.04 | Yes | –0.45/–0.13 | Yes | –0.45/–0.18 | Yes |
| 6. Correlation between change scores NRS pain and HOOS-PS is minimal 0.1 stronger than between HOOS-PS and performance-based test | –0.45/0.30 | Yes | –0.45/0.21 | Yes | –0.45/–0.35 | Yes |
| 7. Correlation between changes scores NRS pain and OHS minimal 0.1 stronger than between NRS pain and performance-based test | –0.66/–0.04 | Yes | –0.66/–0.13 | Yes | –0.66/–0.18 | Yes |
| 8. Correlation between change scores NRS pain and OHS is minimal 0.1 stronger than between OHS and performance-based test | –0.66/0.23 | Yes | –0.66/0.27 | Yes | –0.66/–0.26 | Yes |
| Hypothesis confirmed | 4/8 | 4/8 | 4/8 | |||
Patient characteristics. Data are mean (SD) unless otherwise stated
| Total cohort | Reliability analysis | |
|---|---|---|
| (n = 90) | cohort (n = 30) | |
| Age, years | 69 (9.5) | 66 (9.4) |
| Women, n | 61 | 22 |
| BMI | 27 (3.9) | 26 (2.7) |
| Hip abductor strength, N | 196 (7.8) | 219 (7.9) |
| Knee extensor strength, N | 134 (5.7) | 13 (4.3) |

Patients included in the analyses and lost to follow-up.